Results from the multi-cohort Phase I/II ARROW clinical trial, conducted by The University of Texas MD Anderson Cancer Center researchers, showed that a once-daily dose of pralsetinib, a highly selective RET inhibitor, was ...
Jun 10, 2021
For older adults, participating in social activities can protect against physical and mental signs of aging, but it may also pose risks, especially for women.
Jun 10, 2021
People who are more prone to boredom and who are socially conservative are more likely to break public-health rules, according to new psychology research.
Jun 10, 2021
Treating transplant patients with mild to moderate cases of COVID-19 with monoclonal antibodies is safe and helps prevent serious illness, according to a Mayo Clinic study recently published in Open Forum Infectious Diseases. ...
Jun 10, 2021
